DepoMed, Inc. (NASDAQ:DEPO)

CAPS Rating: 4 out of 5

A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.

Recs

0
Player Avatar KimLanners (< 20) Submitted: 10/14/2011 1:50:28 PM : Outperform Start Price: $5.15 DEPO Score: -1.85

us pharma

Featured Broker Partners


Advertisement